Ekso bionics reports third quarter 2023 revenue growth of 38%

San rafael, calif., oct. 26, 2023 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended september 30, 2023.

EKSO Ratings Summary

EKSO Quant Ranking